Ações do setor de saúde
| # | Nome | Preços | 24h % | 7d % | 1M % | 1A % | Capitalização de mercado | Últimos 7 dias | |
|---|---|---|---|---|---|---|---|---|---|
| 1 |  LLY Eli Lilly & Co. | 929.23 USD | -1.09% | +0.51% | -6.41% | +23.73% | 876.60 B USD | ||
| 2 |  JNJ Johnson & Johnson | 237.91 USD | -0.20% | -1.09% | -2.50% | +56.94% | 573.34 B USD | ||
| 3 |  ABBV ABBVIE INC. | 205.81 USD | -1.06% | -0.08% | -6.92% | +15.99% | 363.91 B USD | ||
| 4 |  MRK Merck & Co., Inc. | 120.22 USD | -0.99% | +0.55% | +4.23% | +50.24% | 297.23 B USD | ||
| 5 |  NVS Novartis AG | 154.35 USD | +0.25% | +1.91% | +0.19% | +44.02% | 294.52 B USD | ||
| 6 |  UNH UNITEDHEALTH GROUP INCORPORATED (Delaware) | 310.96 USD | +2.15% | +0.84% | +9.38% | -47.74% | 282.25 B USD | ||
| 7 |  TMO Thermo Fisher Scientific, Inc. | 510.71 USD | +2.95% | +5.44% | +8.57% | +14.12% | 189.72 B USD | ||
| 8 |  AMGN Amgen Inc | 349.82 USD | -0.34% | +2.83% | -5.30% | +22.05% | 188.58 B USD | ||
| 9 |  ABT Abbott Laboratories | 100.55 USD | +0.27% | -1.32% | -7.62% | -21.17% | 174.72 B USD | ||
| 10 |  GILD Gilead Sciences Inc | 139.03 USD | 0.00% | +0.02% | -3.61% | +33.71% | 172.59 B USD | ||
| 11 |  ISRG Intuitive Surgical Inc. | 458.96 USD | +1.85% | +1.76% | -3.03% | -9.32% | 162.99 B USD | ||
| 12 |  PFE Pfizer Inc. | 27.49 USD | +2.16% | -0.69% | +2.96% | +24.50% | 156.32 B USD | ||
| 13 |  DHR Danaher Corporation | 195.36 USD | +3.03% | +2.17% | +3.26% | +1.70% | 138.15 B USD | ||
| 14 |  SYK Stryker Corporation | 346.39 USD | +2.12% | +4.97% | +2.15% | -2.08% | 132.56 B USD | ||
| 15 |  GSK GSK plc American Depositary Shares (Each representing two Ordinary Shares) | 58.8900 USD | +1.17% | +5.35% | +8.57% | +34.30% | 127.07 B USD | ||
| 16 |  BMY Bristol-Myers Squibb Co. | 58.09 USD | -0.90% | -1.74% | -2.29% | +12.73% | 118.30 B USD | ||
| 17 |  SNY Sanofi American Depositary Shares (Each representing one-half of one ordinary share) | 46.96 USD | +0.43% | -0.28% | +6.85% | -8.66% | 114.53 B USD | ||
| 18 |  MDT Medtronic plc | 87.9610 USD | +0.91% | +2.21% | +0.61% | -6.25% | 112.93 B USD | ||
| 19 |  VRTX Vertex Pharmaceuticals Inc | 440.05 USD | +0.87% | +1.04% | -7.39% | -9.51% | 111.79 B USD | ||
| 20 |  HCA HCA Healthcare, Inc. | 494.91 USD | -0.11% | +2.40% | -7.47% | +47.05% | 110.67 B USD |
Notícias Ações do setor de saúde
Ações da Cellectis mantêm classificação de desempenho superior com base na plataforma alogênica
Harrow: Probably A Short-Term Market Overreaction (NASDAQ:HROW)
US stock futures climb as traders cling to de-escalation hopes, await earnings
Company News for Apr 14, 2026
Asgard Therapeutics nomeia Wolfram Brugger como diretor médico
Grainger nomeia Fiona Muldoon como diretora não executiva
Allogene Therapeutics, Inc. (ALLO) Discusses Interim Futility Analysis from Pivotal Phase II ALPHA 3 Trial in First-Line Consolidation Large B-Cell Lymphoma - Slideshow (NASDAQ:ALLO) 2026-04-14
Gainers Ações do setor de saúde
 QNCX Quince Therapeutics, Inc. Common Stock | 1.41 | +907.14% |
 AKAN Akanda Corp. Common Shares | 3.01 | +377.78% |
 RVMDW Revolution Medicines, Inc. Common Stock | 4.4100 | +123.86% |
 NRXPW NRX Pharmaceuticals, Inc. Common Stock | 0.0120 | +87.50% |
 VRAX Virax Biolabs Group Limited Ordinary Shares | 0.17 | +70.00% |
 RVMD Revolution Medicines, Inc. Common Stock | 136.3000 | +41.35% |
 GCTK GlucoTrack, Inc. Common Stock | 0.8780 | +32.11% |
 HURA TuHURA Biosciences, Inc. Common Stock | 2.87 | +26.43% |
Losers Ações do setor de saúde
 REPL Replimune Group, Inc. | 1.70 | -64.29% |
 WORX SC WORX Corp | 1.06 | -30.72% |
 ONCO Onconetix, Inc. Common Stock | 0.8000 | -26.61% |
 XAIR Beyond Air, Inc. Common Stock | 0.63 | -18.18% |
 QSIAW Quantum-Si Incorporated Class A Common Stock | 0.0900 | -17.20% |
 ZNTL Zentalis Pharmaceuticals, Inc. Common Stock | 5.56 | -15.89% |
 CLGN CollPlant Biotechnologies Ltd Ordinary Shares | 0.32 | -15.79% |
 BFRIW Biofrontera Inc. Common Stock | 0.0400 | -15.61% |